122 related articles for article (PubMed ID: 31175917)
1. Clear cell papillary renal cell carcinoma: molecular profile and virtual karyotype.
Morlote DM; Harada S; Batista D; Gordetsky J; Rais-Bahrami S
Hum Pathol; 2019 Sep; 91():52-60. PubMed ID: 31175917
[TBL] [Abstract][Full Text] [Related]
2. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
3. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
[TBL] [Abstract][Full Text] [Related]
4. Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with single-nucleotide polymorphism microarrays.
Monzon FA; Alvarez K; Gatalica Z; Bridge JA; Nelson M; Kim HJ; Hagenkord JM
Arch Pathol Lab Med; 2009 Dec; 133(12):1917-22. PubMed ID: 19961245
[TBL] [Abstract][Full Text] [Related]
5. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases.
Alaghehbandan R; Ulamec M; Martinek P; Pivovarcikova K; Michalova K; Skenderi F; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2019 Feb; 38():80-86. PubMed ID: 30502717
[TBL] [Abstract][Full Text] [Related]
6. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
9. Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block.
Lan TT; Keller-Ramey J; Fitzpatrick C; Kadri S; Taxy JB; Segal JP; Furtado LV; Antic T
Virchows Arch; 2016 Jul; 469(1):81-91. PubMed ID: 27173781
[TBL] [Abstract][Full Text] [Related]
10. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
[TBL] [Abstract][Full Text] [Related]
11. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI
J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
[TBL] [Abstract][Full Text] [Related]
13. Clear Cell Papillary Renal Cell Carcinoma.
Zhao J; Eyzaguirre E
Arch Pathol Lab Med; 2019 Sep; 143(9):1154-1158. PubMed ID: 30672334
[TBL] [Abstract][Full Text] [Related]
14. Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality.
Kim HJ; Shen SS; Ayala AG; Ro JY; Truong LD; Alvarez K; Bridge JA; Gatalica Z; Hagenkord JM; Gonzalez-Berjon JM; Monzon FA
Am J Surg Pathol; 2009 Sep; 33(9):1276-86. PubMed ID: 19461508
[TBL] [Abstract][Full Text] [Related]
15. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
17. Trisomy 3 in renal cell carcinoma.
Renshaw AA; Fletcher JA
Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314
[TBL] [Abstract][Full Text] [Related]
18. "Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases.
Pivovarcikova K; Peckova K; Martinek P; Montiel DP; Kalusova K; Pitra T; Hora M; Skenderi F; Ulamec M; Daum O; Rotterova P; Ondic O; Dubova M; Curik R; Dunatov A; Svoboda T; Michal M; Hes O
Virchows Arch; 2016 Jul; 469(1):71-80. PubMed ID: 27072821
[TBL] [Abstract][Full Text] [Related]
19. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
[TBL] [Abstract][Full Text] [Related]
20. Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.
Deml KF; Schildhaus HU; Compérat E; von Teichman A; Storz M; Schraml P; Bonventre JV; Fend F; Fleige B; Nerlich A; Gabbert HE; GaBler N; Grobholz R; Hailemariam S; Hinze R; Knüchel R; Lhermitte B; Nesi G; Rüdiger T; Sauter G; Moch H
Am J Surg Pathol; 2015 Jul; 39(7):889-901. PubMed ID: 25970683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]